tirzepatide phase 2 obesity did not impact metabolic adaptation in people with obesity, but increased fat oxidation Read now: The SURPASS-EARLY trial

In-house analytical laboratories

Quarterly liver panels for the first six months

Check your blood sugar If you use tirzepatide for diabetes management, check your blood glucose more frequently for the next few days

Your provider should establish a monitoring schedule including periodic check-ins, assessment of gastrointestinal tolerability, and repeat labs (glucose, kidney function) at 3 months and annually

Clinical trials for semaglutide, including the STEP program that evaluated Wegovy in more than 4,500 participants, documented nausea, vomiting, diarrhea, and constipation as the most frequent side effects

Kapsel mit Retatrutide (GLP-3) und Ascorbinsure